Regulatory Approval in US
Critical for market entry and revenue growth
- Materiality
- high
Sedana Medical
Sedana Medical is a Swedish company based in Danderyd that specializes in developing, manufacturing, and selling medical devices and pharmaceuticals. The company is renowned for its innovative therapy for inhaled sedation in intensive care units, which includes the Sedaconda ACD device and Sedaconda® (isoflurane). Sedana Medical is the parent company of the Sedana Medical Group and operates with a focus on high gross margins and a concentrated customer base, primarily hospitals with intensive care units. The company aims to make inhaled sedation a standard therapy across Europe and is preparing for a significant market entry into the United States.
122
2.88
2.04
| % | |
|---|---|
| Medical Devices | 40% Includes Sedaconda ACD for inhaled sedation |
| Pharmaceuticals | 30% Includes Sedaconda® (isoflurane) for sedation |
| Accessories | 15% Additional products supporting sedation therapy |
| Clinical Trials | 10% Services related to clinical trials and research |
| Commercialization Services | 5% Efforts to market and sell sedation therapies |
Sedana Medical primarily serves hospitals with intensive care units, focusing on those that require advanced sedation...
- Hospitalsprimary
Purchase Sedaconda ACD and Sedaconda® for ICU sedation
- Healthcare Providersprimary
Use inhaled sedation for efficient patient care
- Clinical Research Organizationssecondary
Engage in clinical trials for sedation therapies
Sedana Medical is headquartered in Danderyd, Sweden, and has a strong presence across Europe, with market...
- •Headquartered in Danderyd, Sweden
- •Strong presence in 15 European countries
- •Preparing for US market entry
- •Products sold in over 40 countries
- •Acquisition of Innovatif Cekal in Malaysia for supply chain control
Sedana Medical's strategic priorities include achieving profitable sales growth in Europe, maximizing opportunities in...
01
Profitable Sales Growth in Europemedium-term
To establish inhaled sedation as a standard therapy
02
US Market Entrylong-term
Largest potential market with high ICU bed count
03
Long-term Profitabilitylong-term
High gross margins and concentrated customer base
Key risks for Sedana Medical include regulatory approval challenges in the US, competition from established sedation...
Competition
Established intravenous sedation methods
- Materiality
- medium
ICU Occupancy Rates
Directly impacts sales volume
- Materiality
- medium
Currency Fluctuations
Impacts financial performance due to international operations
- Materiality
- medium
Currency Effects
Seasonality
Short-term Investments
Goodwill and Integration Costs
LEXICON PHARMACEUTICALS, INC.
LXRX · Pharmaceutical Preparations
Lexicon Pharmaceuticals is a U.S.-based biopharmaceutical company focused on discovering, developing, and commercializing small-molecule medicines.
Medinotec Inc.
MDNC · Surgical & Medical Instruments & Apparatus
Sionna Therapeutics, Inc.
SION · Pharmaceutical Preparations
Sonoma Pharmaceuticals, Inc.
SNOA · Surgical & Medical Instruments & Apparatus
Sonoma Pharmaceuticals develops and sells stabilized hypochlorous acid (HOCl) products used in wound care, eye care, oral care, dermatology, podiatry, animal health care, and surface disinfection.
ICU MEDICAL INC/DE
ICUI · Surgical & Medical Instruments & Apparatus
ICU Medical develops, manufactures, and sells medical devices and software used in infusion therapy, vascular access, and critical care settings.
Anebulo Pharmaceuticals, Inc.
ANEB · Pharmaceutical Preparations
: 11/08/2026